Group 1 - The core viewpoint of the news is that the Chinese medical device and equipment trading platform has been launched in Tianjin, which aims to facilitate global trade in medical devices and equipment, thereby promoting the export of domestic medical products and enhancing cross-border industrial cooperation [1] - The China International Medical Equipment and Instrument Trading Platform will provide services such as online display of pharmaceutical products, procurement information, policy information collection and publication, and market operation data analysis [1] - The medical industry is experiencing a new high due to the continuous demand for pharmaceuticals and the increasing unmet needs, along with pharmaceutical companies increasing their R&D investments to meet these demands [1] Group 2 - The CSI Medical and Medical Device Innovation Index (931484) has shown a positive performance, with a 0.34% increase, and notable gains in constituent stocks such as Teva Bio and New Hope [1] - The top ten weighted stocks in the CSI Medical and Medical Device Innovation Index account for 63.9% of the index, including companies like WuXi AppTec, Mindray Medical, and Hengrui Medicine [2] - The medical innovation ETF closely tracks the CSI Medical and Medical Device Innovation Index, reflecting the overall performance of profitable and growth-oriented medical and medical device companies [2]

Group 1 - The core viewpoint of the news highlights the growth and investment opportunities in the brain-computer interface (BCI) market, particularly in China, with significant funding and technological advancements being made by domestic companies [1][2] - The China Medical and Medical Device Innovation Index (931484) has shown a positive performance, with a 0.78% increase, and notable gains in constituent stocks such as TeBao Bio and XinHe Cheng [1] - The global brain-computer interface market is projected to reach approximately $2.62 billion in 2024, with an expected growth to $2.94 billion in 2025 and a compound annual growth rate of 17.35% over the next decade [2] Group 2 - The Chinese brain-computer interface market is anticipated to grow from 3.2 billion yuan in 2024 to 6.14 billion yuan by 2028, indicating a strong domestic market potential [2] - Recent funding of 300 million yuan in A+ round financing for ZhiRan Medical will be utilized for large-scale clinical trials and product iterations, marking a significant step in the application of invasive brain-computer interfaces [1] - The top ten weighted stocks in the China Medical and Medical Device Innovation Index account for 63.9% of the index, with companies like WuXi AppTec and Mindray Medical leading the list [2]

2月10日，三大指数涨跌不一，创新药板块表现强势。截至当日收盘，恒生沪深港创新药精选50指数 (HSSSHID.HK)上涨2.26%收获六连阳，该指数成分股中，信立泰上涨近7%，石药集团与荣昌生物 （A）上涨超5%，信达生物上涨近5%。 海通国际证券指出，港股医药板块经历前期连续调整后，市场情绪有所回暖。随着港股业绩期临近，我 们看好业绩确定性强的互联网医疗、CXO/科研服务龙头。此外，我们建议持续关注本轮调整中回调幅 度较大的优质创新药龙头企业。 相关ETF方面，wind金融终端显示，截至当日收盘，创新药ETF天弘（517380）成交额超3700万元。资 金流向方面，截至2月9日，该ETF已连续3个交易日获资金净流入，累计净流入额为4166.12万元。该 ETF最新流通份额为25.04亿份，最新流通规模为19.63亿元。此外，生物医药ETF（159859）当日成交 额超1亿元，居同标的产品第一。该ETF最新流通份额为95.96亿份，最新流通规模为37.96亿元。 （文章来源：21世纪经济报道） 创新药ETF天弘（517380）为全市场唯一一只跟踪恒生沪港深创新药精选50指数的ETF，汇聚中国硬核 创新药力量 ...

Core Viewpoint - The Shanghai 180 ETF Index Fund closely tracks the Shanghai 180 Index, which reflects the overall performance of 180 large-cap and liquid securities in the Shanghai stock market, showing a recent upward trend in both the index and the fund itself [1][2]. Performance Summary - As of February 10, 2026, the Shanghai 180 Index increased by 0.26%, with notable gains from stocks such as China Power (+9.99%) and Dongfang Electric (+8.34%) [1]. - The Shanghai 180 ETF Index Fund rose by 0.24%, with a latest price of 1.26 yuan, and has accumulated a 1.37% increase over the past week [1]. - The fund's trading volume was 23.03 thousand yuan on February 10, with an average daily trading volume of 65.87 thousand yuan over the past week [1]. Fund Size and Growth - The Shanghai 180 ETF Index Fund experienced a significant growth of 622.11 thousand yuan in size over the past year [1]. - The fund has a Sharpe ratio of 1.91 since its inception, indicating a favorable risk-adjusted return [1]. Fee Structure - The management fee for the Shanghai 180 ETF Index Fund is set at 0.15%, while the custody fee is 0.05% [1]. Tracking Accuracy - As of February 10, 2026, the tracking error of the Shanghai 180 ETF Index Fund over the past three months is 0.019%, demonstrating its effectiveness in tracking the underlying index [1]. Top Holdings - As of January 30, 2026, the top ten weighted stocks in the Shanghai 180 Index account for 24.85% of the index, including major companies like Zijin Mining and Kweichow Moutai [2]. - The top ten stocks by weight are: - Zijin Mining (4.03%) - Kweichow Moutai (4.22%) - China Ping An (2.87%) - Hengrui Medicine (2.46%) - WuXi AppTec (2.08%) - Cambricon (1.97%) - China Merchants Bank (2.04%) - Yangtze Power (1.88%) - SMIC (1.80%) - Industrial Fulian (1.79%) [3].

Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of PANACRO (Hangzhou) Pharmaceutical Technology Co., Ltd. 博納西亞 (杭 州 )醫藥科技股份有 ...

Group 1: Market Overview - The Hong Kong stock market indices collectively rose, with the Hang Seng Index increasing by 0.58% to 27,183.15 points, the Hang Seng China Enterprises Index up by 0.81% to 9,242.75 points, and the Hang Seng Tech Index rising by 0.62% to 5,451.03 points [2] - Major technology stocks mostly saw gains, with JD.com, Xiaomi, and Alibaba each rising over 1% [3] Group 2: AI Application Stocks - AI application stocks experienced a significant surge, with Zhiyun rising over 21% at one point and closing up over 14%. Other notable gains included Reading Group up over 15% and Fubo Group up over 13% [5] - The attention on AI stocks was driven by the launch of a mysterious model named Pony Alpha on the OpenRouter platform, which quickly became popular among global developers due to its strong coding capabilities and deep optimization for intelligent workflows [5] Group 3: Biotechnology Sector - The biotechnology sector also performed well, with notable increases in stocks such as Fuhong Hanlin up over 7%, and WuXi Biologics and Rongchang Biologics each rising over 4% [6] - Guojin Securities anticipates a performance disclosure window for innovative drug companies in February and March, with expectations for many to reduce losses or turn profitable by 2026, supported by upcoming academic conferences [6]

Macro Dynamics - Five departments, including the Ministry of Industry and Information Technology, are accelerating the development of guidelines for the utilization and technological innovation of low-altitude economic radio frequency resources to support low-altitude infrastructure development [2] Health and Safety - The National Health Commission has warned against "light medical beauty" projects being conducted by non-medical institutions, emphasizing that such procedures must be performed in qualified medical facilities by licensed professionals to mitigate health risks [3] Market Data - The State Administration for Market Regulation conducted a special inspection of food safety ahead of the Spring Festival, testing 67,000 batches with a compliance rate of 98.38%, indicating overall good food safety conditions [4] - The National Healthcare Security Administration announced the results of the first to eighth batches of national drug procurement, involving 316 commonly used drugs and 1,020 enterprises with 4,163 products qualifying for selection [5] Financial Institutions - China Bank has increased its registered capital from approximately 294.4 billion RMB to about 322.2 billion RMB, marking an increase of approximately 9.5% [6] Market Performance - On February 10, the A-share market showed mixed results, with the Shanghai Composite Index rising by 0.13% and the ChiNext Index falling by 0.37%, while the total trading volume was approximately 2,105.5 billion RMB, a decrease of about 143.9 billion RMB from the previous trading day [7] - The Hong Kong stock market closed with the Hang Seng Index up by 0.58% and the Hang Seng Tech Index up by 0.62%, driven by significant gains in the pharmaceutical and media sectors [8] Company Dynamics - *ST Lifan announced that its stock will resume trading on February 11 after completing an investigation into stock price fluctuations, noting that the company's fundamentals have not changed significantly [9] - Semiconductor Manufacturing International Corporation reported a net profit of 1.223 billion RMB for Q4 2025, a year-on-year increase of 23.2%, with total revenue of 17.813 billion RMB, up 11.9% [11] - WeChat has launched a "national subsidy" interest service for credit card bill installment repayments, with seven banks participating in the initial rollout [10] - Chow Tai Fook confirmed that it will raise prices for gold products after the Spring Festival, although the timing and extent of the increase have yet to be determined [13] - Sam's Club, Hema, and Dingdong Maicai announced adjustments to service arrangements and delivery fees during the Spring Festival period [15]

Market Overview - The Hong Kong stock market saw all three major indices close higher, with the Hang Seng Index rising by 0.58% to 27,183.15 points, the Hang Seng China Enterprises Index increasing by 0.81% to 9,242.75 points, and the Hang Seng Tech Index up by 0.62% to 5,451.03 points [2] AI Application Stocks - AI application stocks experienced a significant surge, with Zhiyuan (智谱) rising over 21% at one point and closing up by more than 14%. Other notable gains included Reading Group (阅文集团) up over 15% and Fubo Group (阜博集团) up over 13% [6][4] - The excitement in the AI sector was driven by the launch of a new model named Pony Alpha on the OpenRouter platform, which quickly gained popularity among global developers due to its strong coding capabilities and optimized performance for intelligent agent workflows [6] Biotechnology Sector - The biotechnology sector also performed well, with notable stocks such as Fuhong Hanlin (复宏汉霖) increasing by over 7%, and WuXi Biologics (药明生物) and WuXi AppTec (药明康德) both rising by over 4% [9][10] - Analysts from Guojin Securities anticipate a positive earnings disclosure window for innovative drug companies in February and March, with expectations of reduced losses or profitability for several firms by 2026. Upcoming academic conferences are expected to further validate clinical data for domestic innovative drugs [9]

Market Performance - The Hang Seng Index closed up 0.58%, the Hang Seng Tech Index rose 0.62%, and the Hang Seng China Enterprises Index increased by 0.81% [1] - The optical communication sector led the gains, with Longi Fiber Optics rising by 8.8%, Dongfang Electric up over 7%, and Weichai Power increasing by 3.69% [1] Sector Highlights - The cultural media sector saw significant gains, with Digital Kingdom surging over 29%, Reading Group rising over 15%, and DaMai Entertainment and China Ruyi both increasing by over 5% [1] - Biopharmaceutical stocks strengthened, with WuXi AppTec rising over 4%, Rongchang Bio up 3.64%, and Kailai Ying increasing by 3.5% [2] Individual Stock Movements - Notable individual stock movements included Digital Kingdom with a rise of 29.31%, Mao Yi Chuang up 21.92%, and Wan Ka Yi Lian increasing by 20% [2] - The education sector experienced declines, with Dongfang Zhenxuan down over 9% and New Oriental-S falling over 4% [4] New Listings - Le Xin Outdoor debuted with a remarkable increase of 102.29%, closing at 24.78 HKD, and at one point, it surged over 130% during trading [4] AI and Technology Developments - The stock of Zhipu AI, referred to as the "first global large model stock," saw a peak increase of over 24%, with a two-day cumulative rise exceeding 56% [5] - The release of the AI video generation model Seedance 2.0 by ByteDance is expected to significantly reduce production costs and enhance efficiency in the AI drama and short drama sectors, potentially accelerating industry growth [7]

Market Overview - The Hong Kong stock market showed initial gains but narrowed its increase, with the Hang Seng Index closing up 0.58% above 27,000 points, while the Hang Seng China Enterprises Index and Hang Seng Tech Index rose by 0.81% and 0.62% respectively [1][2]. Sector Performance - Technology stocks rebounded, driven by AI application stocks, with the stock of Reading Group surging over 15%. The film and entertainment sector remained active, and the biopharmaceutical sector saw widespread gains, led by Fuhong Hanlin [3][4]. - New consumption concept stocks, paper industry stocks, home appliance stocks, shipping stocks, and automotive stocks mostly increased. Conversely, education stocks faced declines, with gaming stocks collectively sluggish, and real estate, gas, electric, and telecom stocks also underperformed [3][4]. Notable Stocks - AI application stocks saw significant gains, with Reading Group rising 15.41%, and Zhiyun up 14.81%, reaching a new historical high during the session. Other stocks like Fubo Group and Yidu Technology also experienced increases [6][8]. - In the film sector, Orange Sky Entertainment rose over 7%, with other companies like Damai Entertainment and Ningmeng Film also following suit [10]. - The biopharmaceutical sector was buoyed by Fuhong Hanlin's increase of over 7%, with other companies like WuXi Biologics and WuXi AppTec also seeing gains [12]. Industry Insights - The real estate sector faced pressure, with Shimao Group dropping over 6% amid ongoing sales challenges in the industry. Major real estate companies are reportedly initiating organizational restructuring [13][14]. - Education stocks struggled, with Guangzheng Education falling over 5%, alongside declines in New Oriental and other educational institutions [15]. Investment Outlook - According to Everbright Securities, the current liquidity environment in the Hong Kong stock market is entering an observation period, with limited space for further tightening. Positive catalysts could lead to a recovery in market sentiment and capital inflow [22].